DE60028248D1 - Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen - Google Patents

Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen

Info

Publication number
DE60028248D1
DE60028248D1 DE60028248T DE60028248T DE60028248D1 DE 60028248 D1 DE60028248 D1 DE 60028248D1 DE 60028248 T DE60028248 T DE 60028248T DE 60028248 T DE60028248 T DE 60028248T DE 60028248 D1 DE60028248 D1 DE 60028248D1
Authority
DE
Germany
Prior art keywords
amino acid
acid sequence
immunogenicity
protein
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60028248T
Other languages
English (en)
Other versions
DE60028248T2 (de
Inventor
Adriana Warmerdam
Daniel Plaisance
Jose Collen
Maeyer Cyriel De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thromb X NV
Original Assignee
Thromb X NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thromb X NV filed Critical Thromb X NV
Application granted granted Critical
Publication of DE60028248D1 publication Critical patent/DE60028248D1/de
Publication of DE60028248T2 publication Critical patent/DE60028248T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60028248T 1999-12-02 2000-12-01 Verfahren zur Reduzierung der Immunogenität von Staphylokinase durch Entfernen von T-Zell-Epitopen Expired - Fee Related DE60028248T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99204093 1999-12-02
EP99204093 1999-12-02
PCT/EP2000/012299 WO2001040281A2 (en) 1999-12-02 2000-12-01 Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes

Publications (2)

Publication Number Publication Date
DE60028248D1 true DE60028248D1 (de) 2006-06-29
DE60028248T2 DE60028248T2 (de) 2007-03-15

Family

ID=8240963

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60028248T Expired - Fee Related DE60028248T2 (de) 1999-12-02 2000-12-01 Verfahren zur Reduzierung der Immunogenität von Staphylokinase durch Entfernen von T-Zell-Epitopen

Country Status (7)

Country Link
US (1) US20030134335A1 (de)
EP (1) EP1252183B1 (de)
CN (1) CN100335498C (de)
AT (1) ATE327251T1 (de)
AU (1) AU2363301A (de)
DE (1) DE60028248T2 (de)
WO (1) WO2001040281A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002098454A2 (en) * 2001-05-31 2002-12-12 D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
WO2002096454A1 (en) * 2001-05-31 2002-12-05 D. Collen Research Foundation Vzw Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
AU2002360330A1 (en) * 2001-11-13 2003-05-26 Genencor International, Inc. Identifying and reducing the allergenicity of food proteins
US20040018568A1 (en) * 2002-07-23 2004-01-29 Subhashis Banerjee Methods for detecting deantigenized T cell epitopes and uses thereof
WO2004063963A2 (en) * 2003-01-08 2004-07-29 Xencor, Inc. Novel proteins with altered immunogenicity
EP1638993A4 (de) * 2003-06-10 2007-05-09 Univ Melbourne Immunmodulierende zusammensetzungen, anwendungen davon und verfahren zu deren herstellung
US8452541B2 (en) * 2007-06-18 2013-05-28 Microsoft Corporation Vaccine design methodology
CA2691539C (en) 2007-06-21 2014-08-26 Angelica Therapeutics, Inc. Modified toxins
TR201001630T1 (tr) * 2007-10-09 2010-05-21 Thrombogenics N.V. Stafilokinaz varyantı.
WO2009110944A1 (en) * 2008-02-29 2009-09-11 Angelica Therapeutics, Inc. Modified toxins
CA2902905A1 (en) 2013-03-15 2014-09-25 Claude Geoffrey Davis Modified toxins
CN109002690B (zh) * 2018-06-08 2021-05-18 济南大学 通过构建charmm rotamers力场预测突变氨基酸侧链结构的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69833755T2 (de) * 1997-05-21 2006-12-28 Biovation Ltd. Verfahren zur herstellung von nicht-immunogenen proteinen
EP1053330B1 (de) * 1998-02-04 2005-05-04 Thromb-X N.V. Identifizierung, produktion und verwendung von staphylokinase derivaten mit reduzierter immunogenizität und/oder reduzierter 'clearance'
US6835550B1 (en) * 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
JP2002534959A (ja) * 1998-12-08 2002-10-22 バイオベーション リミテッド 免疫原性タンパク質の改変方法

Also Published As

Publication number Publication date
EP1252183B1 (de) 2006-05-24
WO2001040281A3 (en) 2001-12-20
ATE327251T1 (de) 2006-06-15
DE60028248T2 (de) 2007-03-15
US20030134335A1 (en) 2003-07-17
WO2001040281A2 (en) 2001-06-07
AU2363301A (en) 2001-06-12
CN1414972A (zh) 2003-04-30
EP1252183A2 (de) 2002-10-30
CN100335498C (zh) 2007-09-05

Similar Documents

Publication Publication Date Title
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
ATE468127T1 (de) Ii-key/antigene epitop-hybrid-peptid-vakzine
DE60028248D1 (de) Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen
DE69826465D1 (de) Verfahren zur in vitro evolution von proteinfunktionen
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
RU98118184A (ru) Пептидные иммуногены для вакцинации и лечения аллергии
CY1111831T1 (el) Παραγωγα ογκο-συναφους αντιγονου απο την οικογενεια mage και αλληλουχιες νουκλεϊνικου οξεος που κωδικοποιουν αυτα, που χρησιμοποιουνται για την παρασκευη πρωτεϊνων συντηξης και συνθεσεων για εμβολιασμο
CA2290485A1 (en) Method for the production of non-immunogenic proteins
ATE123780T1 (de) Verfahren zur verwendung und herstellung von peptiden.
EP2311952A3 (de) Antikörper gegen MART-1 Protein oder Fragmenten davon
ATE500331T1 (de) Verfahren zur gleichzeitigen herstellung von multiplen proteinen; vektoren und zellen, die hierfür verwendung finden
RU2008120299A (ru) СПОСОБЫ ПОЛУЧЕНИЯ КОМПОЗИЦИЙ, ВКЛЮЧАЮЩИХ ХИТШОКОВЫЕ БЕЛКИ ИЛИ α-2-МАКРОГЛОБУЛИН, ПРИГОДНЫХ ДЛЯ ЛЕЧЕНИЯ ЗЛОКАЧЕСТВЕННОЙ ОПУХОЛИ И ИНФЕКЦИОННОГО ЗАБОЛЕВАНИЯ
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
DE602006016133D1 (de) Verwendung von stefin a als gerüstprotein
DE59509642D1 (de) Verfahren zur modifizierung der stabilität von antikörpern
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
ATE130102T1 (de) Verfahren zur identifizierung oder bestimmung von proteinen und verwendungen dazu.
NZ592340A (en) A method for making a virus vaccine compising Replikin peptides
RU2005106841A (ru) Эпитопы т-клеток в эритропоэтине
ATE387629T1 (de) Gemeinsame epitope von antigenen aus einer multigen-familie
EP1104777A1 (de) Gelatin und ein Verfahren zu dessen Herstellung
RU2004110238A (ru) Модифицированный человеческий гормон роста
ATE473755T1 (de) Methode zur herstellung von (poly)peptiden unter verwendung von verkürzten varianten von sv40 large t antigen mit einem intakten n terminus
WO2004056316A3 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
ATE439368T1 (de) Schnellreifende fluoreszierende proteine und verfahren zu deren anwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee